We performed a prospective, randomised, blinded clinical trial comparing metal versus polyethylene bearing surfaces in patients receiving a THA. Forty-one patients were randomised to receive a metal (twenty-three) or a polyethylene (eighteen) insert with identical femoral and acetabular components. The metal bearing was a 28mm low carbon on high carbon couple. Patients were evaluated pre-operatively, at three, six, twelve months and annually thereafter, including an evaluation of erythrocyte and urine cobalt, chromium, and titanium, outcome measures (WOMAC, SF-12, Harris Hip Score) and radiographs. No patients were lost to follow-up. At an average 7.2 (range 6.1 – 7.8) years follow-up there were no differences in any outcome measures or radiographic findings. Patients receiving metal liners had significantly elevated metal ion measurements. At most recent follow-up, compared to the polyethylene control group, patients receiving a metal on metal bearing had erythrocyte cobalt levels were eleven times elevated (median 1.4 μg/L (metal) vs 0.12 μg/L (poly), p<
.001). Urine cobalt levels were thirty-nine times elevated (median 11.4 μg/L/day (metal) vs 0.29 μg/day (poly), p<
.001) and urine chromium levels were twenty-eight times elevated (median 4.75 μg/day (metal) vs 0.17 μg/day (poly), p<
.001). Additionally the metal ion levels reached an early steady state level and did not decrease over time. (Erythrocyte Co (μg/L): 1.29 (6 mos), 1.20 (1 yr), 1.0 (2 yr), 1.10 (3 yr), 1.35 (4 yr), 1.40 (5 yr)). Both cobalt and chromium ion measurements were significantly elevated in the blood and urine of the patients randomised to receive the metal on metal THA at all time intervals. Contrary to previous reports, in 34% of patients with a metal liner, metal ion (erythrocyte cobalt) elevation was still increasing at latest follow-up, and in the overall metal on metal patient cohort, metal ion median levels were not decreasing over time. As in polyethylene wear data, metal ion results are not necessarily generalizable, but are bearing design specific.
In patients with previous patellectomy the optimal constrained implant is not well understood. Previous outcome studies have shown contradictory results. There interpretation is limited by small number of patients, included primary and revision implants or involved a heterogeneous group of different constraint implants. We performed retrospective match controlled analysis of a posterior stabilised primary total knee arthroplasty in forty-two patients who had previous patellectomy. There were nineteen male and twenty-three female patients. The average age of patients at the time of surgery was fifty-nine years (range from forty-one to seventy-four years). The average time from patellectomy to total knee arthroplasty was seventeen years (range from one to thirty-four years). The average duration of follow-up was 5.3 years with minimum two years follow up (range from two to sixteen years). The control group was matched by age, sex, prosthesis type and surgeon. We used the student-t test to compare the outcome measurement. Preoperatively, the patellectomy and control groups were not significantly different in terms of Knee Society clinical and functional scores or range of motion. Postoperatively clinical component of the knee society score had a significant difference (p<
0.05) however the functional part of the knee society score didn’t (p>
0.05). In patellectomy group the postoperative clinical and functional score were equal to seventy and fifty-eight respectively. The average clinical component of knee society score in the patellectomy group was twelve points (SE=4.8) lower compare to the knee with intact patella. The patellectomy group also had higher extension lag and poorer extension (higher flexion contracture) at the most recent follow up (p<
0.05). This study demonstrated the outcome of the largest series of primary total knee arthroplasty with posterior stabilised implant in patient with previous patellectomy. The outcome of surgery was significantly improved but not as good as the knee with intact patella especially the function of the extensor mechanism.
This study reports on the clinical and wear performance of a prospective randomised controlled trial comparing highly cross-linked (XLPE) to conventional polyethylene (PE) in total hip arthroplasty at five years minimum follow-up. One hundred patients enrolled in a prospective randomised controlled trial received identical hybrid total hip arthroplasties with the exception of the polyethylene insert. Fifty patients received a PE liner (2.5 MRads; gamma-in-nitrogen sterilization) and fifty patients received a XLPE liner (10Mrads; gas-plasma sterilization). Clinical outcomes were determined using Harris Hip, WOMAC and SF-12 scores by an independent study nurse. Femoral head penetration rates were determined using a validated radiographic technique (Hip Analysis Suite 8.0.1.1) based on radiographs at six weeks, one year and yearly post-operatively. Linear regression analysis was performed for both the entire polyethylene groups and on each patient, where the slope represents the steady state head penetration rate (after bedding in) from one to five years follow-up. None of the patients were lost to follow-up, however, nine patients were deceased before their five year follow-up. Two patients have been revised for loose stems. At average follow-up of 6.0 years (range 5.1–6.8 years), there were no differences in Harris Hip, WOMAC or SF-12 scores. XLPE had a significantly lower (p= 0.03) steady-state head penetration rate of 0.018 mm/year compared to 0.050 mm/year for XLPE (approximately 64% reduction). Analysis of individual patient’s head penetration rates demonstrated a similar significantly lower rate with XLPE (0.004 ± 0.067 mm/year) compared to PE (0.045 ± 0.083 mm/year). Interestingly, when examined by gender, the male PE group had a significantly higher head penetration rate (0.081 ± 0.084 mm/year) than both the male and female XLPE (−0.013 ± 0.104, 0.011 ± 0.074 mm/year, respectively). At minimum five years follow-up, there were no clinical differences between groups. After bedding-in, there was a significant lower head penetration rate with XLPE compared to PE. Thus, mid-term follow-up appears to demonstrate a significant wear reduction (based on head penetration rates) afforded by first generation XLPE. Long-term follow-up is required to demonstrate the clinical benefit of this new material.
Locally administered pre-emptive analgesia is effective, reduces central hyper sensitisation and avoids systemic drug related side-effects and may be of benefit in total knee replacement.
All patients received patient controlled analgesia (PCA) for 24 hours post surgery, followed by standard analgesia. Visual Analogue Scale (VAS) pain scores during activity and at rest and patient satisfaction scores were recorded pre and post operatively and at 6 week follow up. PCA consumption and overall analgesic requirement were measured.
Femoral stem fracture occurred in five (2%) of 283 revision hip arthroplasties when extensively coated, distal fixation femoral implants were used. Common features were complex revisions, high body mass index, poor proximal support, smaller stems (<
13.5 mm) and use of an extended trochanteric osteotomy. Use of strut allografts can reduce femoral stem stresses. The purpose of this study was to analyze the surgical factors associated with fracture of cementless distal fixation revision femoral stems and supplement this analysis with a finite element analysis. Data from our institutional joint replacement database identified five (2%) fractured femoral stems (three Solution, two Echelon) in a cohort of two hundred and eighty-three cementless distal fixation femoral stems (one hundred and eighty-two Solution, one hundred and one Echelon) followed over two years. Patient, surgical and implant factors were compared between the fractured and not fractured stems. Finite element analysis was performed on two fractured stem cases to better understand the fracture mechanism. Common clinical features of the five fractured stems were complex revisions, high patient body mass index, poor proximal bone support, smaller stems (<
13.5 mm) and use of an extended trochanteric osteotomy (ETO) (3/5). Fatigue failure was the mode failure in all cases. Finite element analysis confirmed that the location of highest stem stress was near the location of the stem fracture and that use of a strut graft over an extended trochanteric osteotomy in patients lacking proximal femoral cortical support decreased the stem stresses by 48%. Use of cementless distal fixation revision femoral stems is accompanied by a 2% risk of stem fracture in the face of proximal femoral support of the stem and/or use of a stem with a diameter less than 13.5 mm. When an extended trochanteric osteotomy is used, the stem fracture rate increased to 4%. Use of a strut allograft in conjunction with the ETO can reduce stem stresses by 48% and the risk of stem fracture.
We identified five (2.3%) fractures of the stem in a series of 219 revision procedures using a cementless, cylindrical, extensively porous-coated, distally-fixed femoral stem. Factors relating to the patients, the implant and the operations were compared with those with intact stems. Finite-element analysis was performed on two of the fractured implants. Factors associated with fracture of the stem were poor proximal bone support (type III–type IV; p = 0.001), a body mass index >
30; (p = 0.014), a smaller diameter of stem (<
13.5 mm; p = 0.007) and the use of an extended trochanteric osteotomy (ETO 4/5: p = 0.028). Finite-element analysis showed that the highest stresses on the stem occurred adjacent to the site of the fracture. The use of a strut graft wired over an extended trochanteric osteotomy in patients lacking proximal femoral cortical support decreased the stresses on the stem by 48%. We recommend the use of a strut allograft in conjunction with an extended trochanteric osteotomy in patients with poor proximal femoral bone stock.